Victrex plc (VCT) Insider Buys £62,760 in Stock
Victrex plc (LON:VCT) insider Jakob Sigurdsson acquired 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was purchased at an average cost of GBX 2,092 ($27.34) per share, for a total transaction of £62,760 ($82,007.06).
Jakob Sigurdsson also recently made the following trade(s):
- On Monday, February 18th, Jakob Sigurdsson acquired 3,000 shares of Victrex stock. The stock was purchased at an average cost of GBX 2,415 ($31.56) per share, for a total transaction of £72,450 ($94,668.76).
Shares of VCT opened at GBX 2,064 ($26.97) on Friday. The stock has a market capitalization of $1.78 billion and a P/E ratio of 17.95. Victrex plc has a 52-week low of GBX 2,014.55 ($26.32) and a 52-week high of GBX 3,434 ($44.87).
A number of research firms recently weighed in on VCT. Liberum Capital dropped their price objective on shares of Victrex from GBX 2,700 ($35.28) to GBX 2,600 ($33.97) and set a “buy” rating on the stock in a report on Wednesday. JPMorgan Chase & Co. dropped their price objective on shares of Victrex from GBX 2,800 ($36.59) to GBX 2,300 ($30.05) and set a “neutral” rating on the stock in a report on Tuesday. UBS Group reaffirmed a “neutral” rating and issued a GBX 2,225 ($29.07) price objective (down previously from GBX 2,575 ($33.65)) on shares of Victrex in a report on Tuesday. Numis Securities reaffirmed a “hold” rating and issued a GBX 2,350 ($30.71) price objective (down previously from GBX 2,550 ($33.32)) on shares of Victrex in a report on Monday. Finally, Peel Hunt reaffirmed an “add” rating on shares of Victrex in a report on Monday. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of GBX 2,395 ($31.29).
Victrex Company Profile
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Read More: How is inflation measured?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.